How to buy iSpecimen stock (iSpecimen)

iSpecimen is a diagnostics & research business based in the US. iSpecimen shares (ISPC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.81 – a decrease of 6.33% over the previous week. iSpecimen employs 53 staff and has a trailing 12-month revenue of around $10.4 million.

Our top picks for where to buy iSpecimen stock

Buy iSpecimen stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

iSpecimen stock price (NASDAQ: ISPC)

Use our graph to track the performance of ISPC stocks over time.

iSpecimen shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$2.81
52-week range	$2.62 - $12.20
50-day moving average more info button	$4.18
200-day moving average more info button	$5.31
Wall St. target price	$3.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-18.12

Is it a good time to buy iSpecimen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

iSpecimen price performance over time

Historical closes compared with the close of $2.87 from 2024-12-26

1 week (2024-12-20)	-4.33%
1 month (2024-11-29)	-33.10%
3 months (2024-09-27)	-41.43%
6 months (2024-06-27)	811.11%

1 year (2023-12-28)	508.05%
2 years (2022-12-28)	-87.94%
3 years (2021-12-28)	202.4
5 years (2019-12-25)	N/A

iSpecimen financials

Revenue TTM	$10.4 million
Gross profit TTM	$5.6 million
Return on assets TTM	-44.26%
Return on equity TTM	-109.34%
Profit margin	-91.66%
Book value	$5.68
Market Capitalization more info button	$2.7 million

TTM: trailing 12 months

iSpecimen share dividends

We're not expecting iSpecimen to pay a dividend over the next 12 months.

You may also wish to consider:

Have iSpecimen's shares ever split?

iSpecimen's shares were split on a 1:20 basis on 15 September 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your iSpecimen shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for iSpecimen shares which in turn could have impacted iSpecimen's share price.

iSpecimen share price volatility

Over the last 12 months, iSpecimen's shares have ranged in value from as little as $2.6216 up to $12.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while iSpecimen's is 1.593. This would suggest that iSpecimen's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put iSpecimen's beta into context you can compare it against those of similar companies.

• Telesis Bio (TBIO.US): 1.758
• Precision BioSciences (DTIL.US): 1.693
• Teligent (TLGT.US): 1.6943

iSpecimen overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Frequently asked questions

What percentage of iSpecimen is owned by insiders or institutions?
Currently 14.504% of iSpecimen shares are held by insiders and 4.043% by institutions. How many people work for iSpecimen?
Latest data suggests 53 work at iSpecimen. When does the fiscal year end for iSpecimen?
iSpecimen's fiscal year ends in December. Where is iSpecimen based?
iSpecimen's address is: 450 Bedford Street, Lexington, MA, United States, 02420 What is iSpecimen's ISIN number?
iSpecimen's international securities identification number is: US45032V1089